Black seed oil nanoemulsion containing albendazole against protoscoleces of Echinococcus granulosus: An in vivo study

Document Type : Original Article

Authors

1 Natural Products and Medicinal Plants Research Center North Khorasan University of Medical Sciences, Bojnurd, Iran

2 Department of Advanced Technologies, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran

3 Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

4 Department of Parasitology and Mycology, School of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

5 Vector-borne Diseases Research Center North Khorasan University of Medical Sciences, Bojnurd, Iran

10.22038/ijbms.2025.83014.17942

Abstract

Objective(s): Hydatid cysts are typically treated with albendazole. Nevertheless, this drug has side effects and limited bioavailability. In this study, we aimed to explore a nanoemulsion of black seed oil to enhance the therapeutic efficacy of albendazole in mice with hydatid cysts. 
Materials and Methods: The size of the prepared nanoemulsions was characterized using a Zetasizer analyzer. Additionally, the stability of the nanoemulsions was assessed after 45 days. MTT assay was used to compare the cytotoxicity of free albendazole, nanoemulsion containing albendazole, and nanoemulsion without albendazole. Furthermore, infected mice were treated with these preparations, euthanized, and subjected to autopsy examination. Cysts obtained from mice were examined for histopathological features. 
Results: ALB-NE (albendazole-loaded nanoemulsion) DLS results were obtained from black seed oil. Freshly prepared ALB-NE showed (d50 = 170 nm), PDI: 0.323, ALB-NE after 45 days storage at 25 ºC were (d50 = 92.4 nm), and ALB-NE after 45 days storage at 45 ºC revealed (d50 = 118 nm). The cytotoxicity of albendazole was reduced when loaded into the nanoemulsion. Moreover, the group treated with nanoemulsion containing albendazole showed a significant decrease in size and number of cysts compared to those receiving free albendazole or nanoemulsion without the drug. Additionally, after 60 days, the nanoemulsion containing albendazole showed 100% survival, while the survival rate was 50% for free albendazole, 75% for nanoemulsion without albendazole, and 37.5% for PBS. 
Conclusion: The nanoemulsion containing albendazole can be a promising treatment for hydatid cysts.

Keywords

Main Subjects

References

1. Shafiei R, Ghatee M, Jafarzadeh F, Javanshir Z, Karamian M. Genotyping and phylogenetic analysis of unusually located hydatid cysts isolated from humans in north-east Iran. J Helminthol 2020; 94:e64.
2. Zhou T, Xu Y, Gong Y, Yu M, Xu E, Aimaiti W, et al. Breaking-then-curing strategy for efficient cystic echinococcosis therapy. Chin Chem Lett 2022; 33:2949-2953.
3. Firouzeh N, Eslaminejad T, Shafiei R, Faridi A, Fasihi Harandi M. Lethal in vitro effects of optimized chitosan nanoparticles against protoscoleces of Echinococcus granulosus. J Bioact Compat Pol 2021; 36: 237-248.
4. Shafiei R, Mohajerzadeh MS, Masomi HFA, Tavakoli M, Turki H, Firouzeh N. Discordance therapeutic protocol of cystic echinococcosis with WHO guideline: A descriptive study based on liver ultra-sonographic data in North Khorasan province, northeastern of Iran. J Ultrasound Med 2024;43:1279-1287.
5. Moro P, Schantz PM. Echinococcosis: A review. Int J Infect Dis 2009; 13:125-133.
6. Velasco-Tirado V, Alonso-Sardón M, Lopez-Bernus A, Romero-Alegría Á, Burguillo FJ, Muro A, et al. Medical treatment of cystic echinococcosis: systematic review and meta-analysis. BMC Infect Dis 2018; 18:1-19.
7. Siracusano A, Teggi A, Ortona E. Human cystic echinococcosis: old problems and new perspectives. Interdiscip Perspect Infect Dis 2009; 2009:474368.
8. Chai J-Y, Jung B-K, Hong S-J. Albendazole and mebendazole as anti-parasitic and anti-cancer agents: An update. Korean J Parasitol 2021; 59:189-225.
9. Falagas ME, Bliziotis IA. Albendazole for the treatment of human echinococcosis: a review of comparative clinical trials. Am J Med Sci 2007; 334:171-179.
10. Venkatesan P. Albendazole. J Antimicrob Chemother 1998; 41:145-147.
11. Dehkordi AB, Sanei B, Yousefi M, Sharafi SM, Safarnezhad F, Jafari R, et al. Albendazole and treatment of hydatid cyst: review of the literature. Infect Disord Drug Targets 2019; 19:101-104.
12. Hong S-T. Albendazole and praziquantel: Review and safety monitoring in Korea. Infect Chemother 2018; 50:1-10.
13. Azizi M, Chizzola R, Ghani A, Oroojalian F. Composition at different development stages of the essential oil of four Achillea species grown in Iran. Nat Prod Commun 2010; 5:283-290.
14. Azizi M, Tavana M, Farsi M, Oroojalian F. Yield performance of Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (W. Curt.: Fr.) P. Karst.(higher Basidiomycetes), using different waste materials as substrates. Int J Med Mushrooms 2012; 14:521-527.
15. Movahedi R, Razmjoue D, Bahmani M, Lysiuk R, Oroojalian F. Eco‐friendly green synthesis of silver nanoparticles using daphne mucronata royle seeds extract and the potential antibacterial, antifungal, and scolicidal activities. ChemistrySelect 2024; 9:e202403423.
16. Akhlaghi M, Taebpour M, Sharafaldini M, Javani O, Haghiralsadat BF, Oroojalian F, et al. Fabrication, characterization and evaluation of anti-cancer and antibacterial properties of nanosystems containing Hedera helix aqueous extracts. Nanomed J 2022; 9:43-56.
17. Yazdi AM, Hosseini A, Gheibihayat SM, Beygi M, Haghiralsadat BF, Oroojalian F. Characterization, cell toxicity, and antimicrobial activity of a carvacrol-encapsulating nanoliposomal system against Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. Nanomed J 2024; 11: 93-106.
18. Shoorgashti R, Shahrzad H, Nowroozi S, Ghadamgahi B, Mehrara R, Oroojalian F. Evaluation of the antibacterial and cytotoxic activities of Ag/ZnO nanoparticles loaded polycaprolactone/chitosan composites for dental applications. Nanomed J 2023; 10: 68-76.
19. Gholami Z, Dadmehr M, Jelodar NB, Hosseini M, Parizi AP. One-pot biosynthesis of CdS quantum dots through in vitro regeneration of hairy roots of Rhaphanus sativus L. and their apoptosis effect on MCF-7 and AGS cancerous human cell lines. Mater Res Exp 2020; 7:015056.
20. Yousefpoor Y, Esnaashari SS, Baharifar H, Mehrabi M, Amani A. Current challenges ahead in preparation, characterization, and pharmaceutical applications of nanoemulsions. Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol 2023:e1920.
21. Divanbeigi N, Yousefian M, Etemad L, Azizi M, Ebrahimzadeh A, Oroojalian F, et al. Improving the anticancer efficiency of doxorubicin by luteolin nanoemulsion: In vitro study. Nanomed J 2023; 10:47-58.
22. Maghbool M, Khosravi T, Vojdani S, Chaijan MR, Esmaeili F, Amani A, et al. The effects of eugenol nanoemulsion on pain caused by arteriovenous fistula cannulation in hemodialysis patients: A randomized double-blinded controlled cross-over trial. Complement Ther Med 2020; 52:102440.
23. Valizadeh A, Shirzad M, Pourmand MR, Farahmandfar M, Sereshti H, Amani A. Levofloxacin nanoemulsion gel has a powerful healing effect on infected wound in streptozotocin-induced diabetic rats. Drug Deliv Transl Res 2021; 11:292-304.
24. Ammar HO, Salama H, Ghorab M, Mahmoud A. Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. Aaps Pharmscitech 2009; 10:808-819.
25. Amani A, York P, Chrystyn H, Clark BJ. Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers. Aaps Pharmscitech 2010; 11:1147-1151.
26. Khani S, Keyhanfar F, Amani A. Design and evaluation of oral nanoemulsion drug delivery system of mebudipine. Drug Deliv 2016; 23:2035-2043.
27. Chhabra G, Chuttani K, Mishra AK, Pathak K. Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability. Drug Dev Ind Pharm 2011; 37:907-916.
28. Veerareddy PR, Poluri K, Sistla R, Chaganty S, Vennishetty V. Formulation development and comparative pharmacokinetic evaluation of felodipine nanoemulsion in SD rats. Am J PharmTech Res 2012; 2:931-945.
29. Azami SJ, Teimouri A, Keshavarz H, Amani A, Esmaeili F, Hasanpour H, et al. Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice. Int J Nanomedicine 2018; 13:7363-7374.
30. Azami SJ, Amani A, Keshavarz H, Najafi-Taher R, Mohebali M, Faramarzi MA, et al. Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis. Eur J Pharm Sci 2018; 117:138-146.
31. Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, et al. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed 2013; 3:337-352.
32. Pishavar E, Oroojalian F, Ramezani M, Hashemi M. Cholesterol‐conjugated PEGylated PAMAM as an efficient nanocarrier for plasmid encoding interleukin‐12 immunogene delivery toward colon cancer cells. Biotechnol Prog 2020; 36:e2952.
33. Pishavar E, Oroojalian F, Salmasi Z, Hashemi E, Hashemi M. Recent advances of dendrimer in targeted delivery of drugs and genes to stem cells as cellular vehicles. Biotechnol Prog 2021; 37:e3174.
34. Oroojalian F, Rezayan AH, Shier WT, Abnous K, Ramezani M. Megalin-targeted enhanced transfection efficiency in cultured human HK-2 renal tubular proximal cells using aminoglycoside-carboxyalkyl-polyethylenimine-containing nanoplexes. Int J Pharm 2017; 523:102-120.
35. Oroojalian F, Rezayan AH, Mehrnejad F, Nia AH, Shier WT, Abnous K, et al. Efficient megalin targeted delivery to renal proximal tubular cells mediated by modified-polymyxin B-polyethylenimine based nano-gene-carriers. Mater Sci Eng C Mater Biol Appl 2017; 79:770-782.
36. Ahmadnia S, Moazeni M, Mohammadi-Samani S. Hydatid cyst formation in male BALB/c mice following the intraperitoneal injection of live protoscoleces and activated oncospheres: A comparative study. J Parasit Dis 2014; 38:77-80.
37. Rafiei A, Asgarian F, Rahdar M, Jelowdar A, Sabaghan M. Experimental hydatid cyst development in different breeds of mice: A re-evaluation. Biomed Res 2017; 28:1770-1773.
38. Faraji AH, Wipf P. Nanoparticles in cellular drug delivery. Bioorg Med Chem 2009; 17:2950-2962.
39. Petersen JS, Baird SK. Treatment of breast and colon cancer cell lines with anti-he\lmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death. J Cancer Res Clin Oncol 2021; 147:2945-2953.
40. Hashemi-Hafshejani S, Amani A, Azami SJ, Valian HK, Mohebali M, Salimi M, et al. Nanoemulsion of spiramycin against tachyzoites of Toxoplasma gondii, RH strain: Preparation, toxicology, and efficacy studies. Iran J Public Health 2023; 52:1495-1503.
41. Teimouri A, Jafarpour Azami S, Hashemi Hafshejani S, Ghanimatdan M, Bahreini MS, Alimi R, et al. Protoscolicidal effects of curcumin nanoemulsion against protoscoleces of Echinococcus granulosus. BMC Complement Med Ther 2023; 23:124-132.
42. Stuchlík M, Zak S. Lipid-based vehicle for oral drug delivery. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2001; 145:17-26.
43. Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 2000; 50:179-188.
44. Shaker DS, Ishak RA, Ghoneim A, Elhuoni MA. Nanoemulsion: A review on mechanisms for the transdermal delivery of hydrophobic and hydrophilic drugs. Sci Pharm 2019; 87:17-50.
45. Aburahma MH, El-Laithy HM, Hamza YE-S. Oral bioavailability enhancement of vinpocetine using self-microemulsifying drug delivery system containing long chain triglycerides: Preparation and in vitro/in vivo evaluation. Clin Res Reg Affairs 2010; 27:97-107.
Iranian Journal of Basic Medical Sciences
Volume 28, Issue 6
June 2025
Pages 755-761

Files

Share

How to cite

Statistics